Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (121-130 of 241) with videos related to

Pageof 25
Sort By:
Cancer Science|December 28, 2018
Phase I study of alpelisib (BYL719), an α-specific PI3K inhibitor, in Japanese patients with advanced solid tumorsYuichi Ando, Satoru Iwasa, Shunji Takahashi, et al.
Odontology|September 16, 2018
Association between number of pairs of opposing posterior teeth, metabolic syndrome, and obesityTakahiro Iwasaki, Hideki Fukuda, Masayasu Kitamura, et al.
In Vivo (Athens, Greece)|November 4, 2020
Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5'-Deoxy-5-fluorocytidine, and Creatinine ClearanceTakahiro Inaishi, Ken-Ichi Fujita, Natsumi Matsumoto, et al.
Cancer Science|November 24, 2015
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunctionTakashi Shibata, Tomoki Ebata, Ken-ichi Fujita, et al.
Oncology|June 23, 2012
Pharmacokinetic study of S-1 in patients in whom inulin clearance was measuredYuichi Ando, Kenji Kawada, Megumi Inada, et al.
International Cancer Conference Journal|February 4, 2022
Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancerYuko Takano, Satoshi Furune, Yuki Miyai, et al.
World Journal of Gastroenterology|March 2, 2017
Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility studyOsamu Maeda, Ayumu Matsuoka, Ryoji Miyahara, et al.
Cancer Science|September 24, 2010
Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancerTomoya Shimokata, Yuichi Ando, Yoshinari Yasuda, et al.
International Cancer Conference Journal|October 3, 2022
A rapid and durable response to larotrectinib in a patient with <i>NTRK</i> fusion-positive secretory carcinoma originating from the external auditory canalYuichi Ando, Sachi Morita, Tomoya Shimokata, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2005
Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small-cell lung cancer patients: a phase I study of two sequencesMaki Ando, Hideo Saka, Yuichi Ando, et al.
Pageof 25

Showing results (121-130 of 241) with videos related to

Sort By:
Pageof 25
Cancer Science|December 28, 2018
Phase I study of alpelisib (BYL719), an α-specific PI3K inhibitor, in Japanese patients with advanced solid tumorsYuichi Ando, Satoru Iwasa, Shunji Takahashi, et al.
Odontology|September 16, 2018
Association between number of pairs of opposing posterior teeth, metabolic syndrome, and obesityTakahiro Iwasaki, Hideki Fukuda, Masayasu Kitamura, et al.
In Vivo (Athens, Greece)|November 4, 2020
Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5'-Deoxy-5-fluorocytidine, and Creatinine ClearanceTakahiro Inaishi, Ken-Ichi Fujita, Natsumi Matsumoto, et al.
Cancer Science|November 24, 2015
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunctionTakashi Shibata, Tomoki Ebata, Ken-ichi Fujita, et al.
Oncology|June 23, 2012
Pharmacokinetic study of S-1 in patients in whom inulin clearance was measuredYuichi Ando, Kenji Kawada, Megumi Inada, et al.
International Cancer Conference Journal|February 4, 2022
Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancerYuko Takano, Satoshi Furune, Yuki Miyai, et al.
World Journal of Gastroenterology|March 2, 2017
Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility studyOsamu Maeda, Ayumu Matsuoka, Ryoji Miyahara, et al.
Cancer Science|September 24, 2010
Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancerTomoya Shimokata, Yuichi Ando, Yoshinari Yasuda, et al.
International Cancer Conference Journal|October 3, 2022
A rapid and durable response to larotrectinib in a patient with <i>NTRK</i> fusion-positive secretory carcinoma originating from the external auditory canalYuichi Ando, Sachi Morita, Tomoya Shimokata, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2005
Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small-cell lung cancer patients: a phase I study of two sequencesMaki Ando, Hideo Saka, Yuichi Ando, et al.
Pageof 25